XML 57 R31.htm IDEA: XBRL DOCUMENT v3.19.2
EARNINGS PER SHARE (Tables)
12 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Net earnings per share were calculated as follows:
Years ended June 30
2019
 
2018
 
2017
CONSOLIDATED AMOUNTS
Total
 
Total
 
Continuing Operations
Discontinued Operations
Total
Net earnings
$
3,966

 
$
9,861

 
$
10,194

$
5,217

$
15,411

Less: Net earnings attributable to noncontrolling interests
69

 
111

 
85


85

Net earnings attributable to P&G
3,897

 
9,750

 
10,109

5,217

15,326

Less: Preferred dividends, net of tax
263

 
265

 
247


247

Net earnings attributable to P&G available to common shareholders (Basic)
$
3,634

 
$
9,485

 
$
9,862

$
5,217

$
15,079

 
 
 
 
 
 
 
 
Net earnings attributable to P&G available to common shareholders (Diluted)
$
3,634

 
$
9,750

 
$
10,109

$
5,217

$
15,326

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,503.6

 
2,529.3

 
2,598.1

2,598.1

2,598.1

Add: Effect of dilutive securities
 
 
 
 
 
 
 
Impact of stock options and other unvested equity awards (1)
35.9

 
32.5

 
43.0

43.0

43.0

Conversion of preferred shares (2)

 
94.9

 
99.3

99.3

99.3

Diluted weighted average common shares outstanding
2,539.5

 
2,656.7

 
2,740.4

2,740.4

2,740.4

 
 
 
 
 
 
 
 
NET EARNINGS PER SHARE (3)
 
 
 
 
 
 
 
Basic
$
1.45

 
$
3.75

 
$
3.79

$
2.01

$
5.80

Diluted
$
1.43

 
$
3.67

 
$
3.69

$
1.90

$
5.59

(1) 
Weighted average outstanding stock options of approximately 13 million in 2019, 48 million in 2018 and 20 million in 2017 were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the assumed proceeds upon exercise would have exceeded the market value of the underlying common shares).
(2) 
Despite being included in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035. In fiscal year 2019, weighted average outstanding preferred shares of 90 million were not included in the Diluted net earnings per share calculation because to do so would have been antidilutive, due to lower Net earnings driven by the Shave Care impairment charges (see Note 4).
(3) 
Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.